Literature DB >> 3009096

Mixed small cell and non-small cell lung cancer.

D J Adelstein, J F Tomashefski, N J Snow, T P Horrigan, J D Hines.   

Abstract

Seventeen (10 percent) of 176 patients with small-cell carcinoma of the lung seen at this hospital since 1976 proved to have mixed small-cell and non-small-cell tumors. The presence of a mixed lung cancer was established prior to chemotherapy or irradiation in nine patients. Eight were initially diagnosed as pure small-cell carcinoma but proved to have a mixed tumor at either surgery or autopsy. Of the 17 patients, eight received chemotherapy, and four had a partial response. Six of the 40 autopsies performed on patients with small-cell lung cancer demonstrated intrathoracic tumor which was histologically mixed. Extrathoracic metastases in these patients were heterogeneous and included pure small-cell, pure non-small-cell, and mixed histologic type. We conclude that mixed small-cell and non-small-cell lung cancers are relatively frequent and carry important prognostic and therapeutic implications. Clinical management of patients with small-cell lung cancer should therefore be flexible and tailored to the potential for histologic diversity. Mixed lung cancer in previously untreated patients suggests a common endodermal origin for small-cell and non-small-cell pulmonary tumors.

Entities:  

Mesh:

Year:  1986        PMID: 3009096     DOI: 10.1378/chest.89.5.699

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  28 in total

1.  Elevated RABEX-5 protein expression predicts poor prognosis in combined small cell lung cancer.

Authors:  Fuliang Zhang; Meng Zhang; Guohua Hu; Qiling Cai; Tongbai Xu
Journal:  Tumour Biol       Date:  2015-05-23

Review 2.  Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin.

Authors:  Matthew G Oser; Matthew J Niederst; Lecia V Sequist; Jeffrey A Engelman
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

3.  Prognosis of small cell lung cancer patients with diabetes treated with metformin.

Authors:  T Xu; G Liang; L Yang; F Zhang
Journal:  Clin Transl Oncol       Date:  2015-06-11       Impact factor: 3.405

4.  "Combined" small cell and "pure" small cell lung cancer: is there a clinical difference?

Authors:  Young Hak Kim; Michiaki Mishima; Hiroshi Date
Journal:  Med Oncol       Date:  2013-05-12       Impact factor: 3.064

5.  Molecular mechanisms of pathological tumor transformation and their clinical implications: predictors of pulmonary adenocarcinoma transformation into small cell carcinoma.

Authors:  Maria-Rosa Ghigna; Vincent Thomas De Montpréville
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

6.  Characterization of the cell of origin for small cell lung cancer.

Authors:  Kwon-Sik Park; Mei-Chih Liang; David M Raiser; Raffaella Zamponi; Rebecca R Roach; Stephen J Curtis; Zandra Walton; Bethany E Schaffer; Caitlin M Roake; Anne-Flore Zmoos; Christina Kriegel; Kwok-Kin Wong; Julien Sage; Carla F Kim
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

7.  High pretreatment serum C-reactive protein level predicts a poor prognosis for combined small-cell lung cancer.

Authors:  Na Shao; Qiling Cai
Journal:  Tumour Biol       Date:  2015-05-31

8.  Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.

Authors:  Man Qiao; Guohua Hu
Journal:  Tumour Biol       Date:  2015-04-25

Review 9.  Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors.

Authors:  Rita Dorantes-Heredia; José Manuel Ruiz-Morales; Fernando Cano-García
Journal:  Transl Lung Cancer Res       Date:  2016-08

10.  Analysis of unexpected small cell lung cancer following surgery as the primary treatment.

Authors:  Haitang Yang; Jianlin Xu; Feng Yao; Shunqing Liang; Heng Zhao
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-20       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.